Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the feasibility, acceptability, and preliminary impact of text messaging to promote lung cancer screening.
We will conduct a two-arm pilot randomized controlled trial with 40 adults. Participants will be randomized in a 1:1 ratio to either UR Screened (a text messaging program designed to promote lung cancer screening) or a control group (a mailed educational material along with a flyer for the lung cancer screening program). We will assess recruitment and follow-up rates, satisfaction with the program or educational material, and uptake of lung cancer screening at week 12. Additionally, we will compare screening rates between the intervention and control groups.
Age
50 - 80 years
Sex
ALL
Healthy Volunteers
No
University of Rochester Medical Center
Rochester, New York, United States
Start Date
February 17, 2026
Primary Completion Date
August 1, 2026
Completion Date
August 1, 2026
Last Updated
February 19, 2026
40
ESTIMATED participants
Text messaging program
BEHAVIORAL
Educational material
BEHAVIORAL
Lead Sponsor
University of Rochester
NCT05747443
NCT06745258
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03200236